ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,633.09
0.13%
Dow Jones
41,622.08
0.00%
US Dollar vs MXN
19.37875
0.82%
Brent Oil
72.275
-0.47%
Bitcoin
59,120.73
1.61%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
17/09/202406:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:HNDAFHonda Motor Co Ltd (PK)
17/09/202406:37Business WireDataDome: 95% of Advanced Bots Go Undetected on Websites
17/09/202406:36Business WirexSuite Group Expands Its Executive Management Team
17/09/202406:36PR Newswire (US)Leadership Transition and Succession at Waterman Group
17/09/202406:36PR Newswire (US)VENTURE GLOBAL EXPANDS EUROPEAN REGASIFICATION CAPACITY
17/09/202406:32Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:STIMNeuronetics Inc
17/09/202406:32PR Newswire (US)Medunik USA expands Medicaid coverage and patient support services for Pheburane® (sodium phenylbutyrate)
17/09/202406:30GlobeNewswire Inc.Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of DirectorsNASDAQ:KURAKura Oncology Inc
17/09/202406:30GlobeNewswire Inc.Draganfly and Nightingale Security Selected by Fortune 25 Oil and Gas Company to Develop Autonomous Drone-in-a-Box Remote Sensing Solution3U8A.F
17/09/202406:30GlobeNewswire Inc.Rakovina Therapeutics and Variational AI Announce Drug Discovery CollaborationTSXV:RKVRakovina Therapeutics Inc
17/09/202406:30GlobeNewswire Inc.ForwardLane Appoints Industry Leader as New President
17/09/202406:30GlobeNewswire Inc.Amesite Releases Video Shareholder UpdateNASDAQ:AMSTAmesite Inc
17/09/202406:30GlobeNewswire Inc.Brixton Metals Provides Initial Assay Results from its Maiden Drill Program at the Cirque Cu-Mo Porphyry TargetTSXV:BBBBrixton Metals Corporation
17/09/202406:30GlobeNewswire Inc.BridgeBio Announces Infigratinib Is the First Ever Investigational Therapeutic Option for Achondroplasia to Be Awarded Breakthrough Therapy Designation by the FDANASDAQ:BBIOBridgeBio Pharma Inc
17/09/202406:30GlobeNewswire Inc.Atsena Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
17/09/202406:30Business WireEasy Metrics Acquires TZA, Bringing Unmatched Visibility to Warehouse and Labor-Intensive Operations
17/09/202406:30Business WireSara Mitchell to Succeed Mark Gregory as AXIS Head of Global MarketsNYSE:AXSAxis Capital Holdings Ltd
17/09/202406:30Business WireFerrer treibt die Forschung zur progressiven supranukleären Paralyse (PSP) mit der Aufnahme des ersten Teilnehmers in eine klinische Phase-II-Studie voran
17/09/202406:30Business WireFerrer fait progresser la recherche sur la paralysie supranucléaire progressive (PSP) avec l’inclusion du premier participant dans un essai clinique de phase II
17/09/202406:30Business WireIsland Country of Tonga Partners with Everbridge to Enhance Multi-Hazard Early Warning Systems & Response
17/09/202406:30PR Newswire (US)UniDoc Health Partners with Carefluence® to Enhance eHealth InteroperabilityNYSE:TAT&T Inc
17/09/202406:30PR Newswire (US)QuickLogic to Exhibit at GlobalFoundries Technology Summit in MunichNASDAQ:QUIKQuickLogic Corporation
17/09/202406:30PR Newswire (US)AIFRED HEALTH ANNOUNCES HEALTH CANADA APPROVAL FOR THE SALE AND COMMERCIALIZATION OF ITS AI-DRIVEN CLINICAL DECISION SUPPORT DEVICE TO OPTIMIZE TREATMENT CHOICE IN MAJOR DEPRESSION
17/09/202406:30PR Newswire (Canada)AIFRED HEALTH ANNONCE L'APPROBATION PAR SANTÉ CANADA DE LA VENTE ET DE LA COMMERCIALISATION DE SON DISPOSITIF D'AIDE À LA DÉCISION CLINIQUE ALIMENTÉ PAR L'INTELLIGENCE ARTIFICIELLE POUR OPTIMISER LE CHOIX DU TRAITEMENT DE LA DEPRESSION MAJEURE
17/09/202406:30PR Newswire (US)BirchStreet Systems Selected as Exclusive Procure-to-Pay Partner for Red Sea Global in Saudi Arabia
17/09/202406:30PR Newswire (US)OneBill Forges a New Integration Partnership with Pioneer VoIP Virtual Fax Provider, Pangea
17/09/202406:30PR Newswire (US)Clinical Pioneer University of Iowa Health Care Rolls Out Nabla to All Clinicians
17/09/202406:30PR Newswire (US)NEVADA KING IDENTIFIES FIVE HIGH-PRIORITY DRILL-READY REGIONAL EXPLORATION TARGETS
17/09/202406:30PR Newswire (Canada)LIBERO COPPER MOBILIZES FOR EXPLORATION AT THE MOCOA PORPHYRY COPPER-MOLYBDENUM DEPOSITTSXV:LBCLibero Copper & Gold Corporation
17/09/202406:30PR Newswire (US)SISTAS IN SALES ANNOUNCES FAWN WEAVER AS THE KEYNOTE SPEAKER FOR ITS 'SIS SUMMIT,' THE WORLD'S LARGEST CONFERENCE FOR WOMEN OF COLOR IN SALES

Su Consulta Reciente

COIN
DOGEUSD
Dogecoin
FX
USDMXN
US Dollar vs MXN
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
NYSE
AXP
American Express
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
AMEX
XLF
Financial Select Sector
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados